MAPT and dementia: These data suggest that multiplexing P2ry12 with pathological indicators of disease, like TDP-43, NEF-L, and phosphorylated tau S214, could provide additional insight into parsing apart the discrepancies between dementia variant associated protein dysregulation and deposition.